IPO Updates: Bidding Ends for Mobikwik, Vishal Mega Mart, and Sai Life Sciences; Insights on Grey Market Premiums
Stay updated on IPO trends: Mobikwik, Vishal Mega Mart, Sai Life Sciences, and Hamps Bio IPOs showcase mixed grey market premiums. Analyze fundamentals for informed investment decisions.
IPO Updates: Bidding Ends for Mobikwik, Vishal Mega Mart, and Sai Life Sciences; Insights on Grey Market Premiums
Bidding for the initial public offerings (IPOs) of Mobikwik Systems, Vishal Mega Mart, and Sai Life Sciences concluded on Friday, with mixed responses across investor segments. Meanwhile, the IPOs of Inventurus Knowledge Solutions and the International Gemmological Institute (IGI) are set to close on Monday and Tuesday, respectively.
The grey market premiums (GMPs) of these IPOs provide investors with preliminary indications of potential listing gains. However, market experts caution against solely relying on GMP trends, highlighting the importance of analyzing company fundamentals.
Performance Highlights
1. Mobikwik IPO GMP
• Current GMP: Rs 166
• Expected Listing Gain: 59 per cent
• Price Band: Rs 279
2. Vishal Mega Mart IPO GMP
• Current GMP: Rs 20
• Expected Listing Gain: 26 per cent
• Price Band: Rs 78
3. Sai Life Sciences IPO GMP
• Current GMP: Rs 43
• Expected Listing Gain: 8 per cent
4. Inventurus Knowledge Solutions (IKS) IPO GMP
• Current GMP: Rs 376
• Expected Listing Gain: 28 per cent
• Price Band: Rs 1,350
5. International Gemmological Institute (IGI) IPO GMP
• Current GMP: Rs 107
• Expected Listing Gain: 26 per cent
• Price Band: Rs 417
The Hamps Bio IPO, set to be listed on the BSE SME Exchange, witnessed robust demand on its opening day. The IPO was subscribed 11.30 times on Friday, with 1,37,86,000 bids received for 12,20,000 shares.
• Hamps Bio IPO GMP: Rs 40
• Expected Listing Gain: 78 per cent
• Issue Price: Rs 51
• Bidding Ends: December 17, 2024
While GMP trends hint at listing gains, analysts highlight that the grey market operates outside regulated frameworks and does not account for company fundamentals or financial health. Investors are advised to evaluate balance sheets and financial statements before making decisions.
Hamps Bio IPO is all set to deliver the highest premium at 78 per cent, followed by Mobikwik (59 per cent) and IKS (28 per cent). Investors should combine grey market insights with detailed research on company performance to ensure well-informed investment choices.